Arbutus Biopharma Corporation
ABUSBiotechnology
$4.21−1.64%As of Oct 30vs prior close
- Market cap
- $645.3M
- P/E (TTM)
- 5.3×
- P/E (FY1)
- 4.1×
- From 52W high
- −19.35%
- EPS (LTM)
- $0.79
- Revenue (LTM)
- $181.7M
- Net margin
- 84.23%
- Dividend yield
- 0.00%
Nomior Score
59
Discounted QualitySpeculativeTop 29% of the scored universe
Growth36
Quality73
Value68
Momentum46
Resilience57
Growth
+28.34%revenue a year over 9 fiscal years
YE16 $1.5MLTM $181.7M
Connections
Revenue to profitQ2 YE26
The operating loss was 588% of revenue, wider by 602 pts on a year.
Who owns it
2funds